Secil Koseoglu

Title: Secil Koseoglu: Innovator in Antiplatelet Drug Sensitivity Evaluation

Introduction

Secil Koseoglu is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of medical research, particularly in the evaluation of antiplatelet drug sensitivity. Her work is crucial for improving patient outcomes in cardiovascular treatments.

Latest Patents

Secil Koseoglu holds a patent for "Compositions and methods for evaluation of antiplatelet drug sensitivity." This patent focuses on compositions and methods for detecting phosphorylation of dynamin-related protein 1 (Dip1) at position Ser-616. The methods described in her patent are useful for detecting antiplatelet agent sensitivity in a subject and for determining if a subject has been previously exposed to an antiplatelet agent. She has 1 patent to her name.

Career Highlights

Secil Koseoglu is affiliated with Beth Israel Deaconess Medical Center, Inc., where she conducts her research. Her work is recognized for its potential impact on the medical community, particularly in the area of personalized medicine.

Collaborations

Some of her notable coworkers include David Barrios and Robert Flaumenhaft. Their collaborative efforts contribute to advancing research in the field of antiplatelet therapies.

Conclusion

Secil Koseoglu is an influential inventor whose work in antiplatelet drug sensitivity evaluation is paving the way for advancements in cardiovascular treatment. Her contributions are vital for enhancing patient care and understanding drug interactions.